ENGLISH
|
HINDI
APPS
iPhone
|
iPad
|
BlackBerry
|
Android
Nokia
Windows
Network18
Quotes
Quotes
NAVs
News
Messages
People
Notices
Videos
All
FEEDBACK
Facebook
Follow @moneycontrolcom on Twitter
CNBC TV 18
moneycontrol
News
Markets
Mutual Funds
IPO
Commodities
Wealth
Portfolio
Messages
My TV
Tax
Fixed Income
Property
SME
CNBC-TV18
Home
Business
General News
Market Trends
Stocks
Fund News
Personal Finance
Corporate Strategy
Lifestyle
Politics
Legal
Master Your Money
Share
>
Share
Tweet
Share on Tumblr
Ondansetron Hydrochloride
News »
latest
by relevance
Glenmark receives approval for Ondansetron IR & ODT tablets
Jun 29, 2007 at 13:38
Glenmark receives US FDA approval for Ondansetron IR and Ondansetron ODT tablets
Dr Reddy's gets USFDA nod for Ondansetron
Dec 28, 2006 at 08:28
Dr Reddy's Laboratories Ltd today got the final approval for Ondansetron Hydrochloride, the generic equivalent of the blockbuster drug `Zofran', from the US Food and Drug Administration (USFDA), as well as a 6-month marketing exclusivity.
Dr Reddys announces final approval of Ondansetron tablets
Dec 27, 2006 at 13:25
Dr Reddys announces final approval of Ondansetron tablets with 180-days of marketing exclusivity
Glenmark receives tentative approval to mkt Ondansetron HCL
Sep 19, 2006 at 14:30
Glenmark receives US FDA tentative approval to market generic Ondansetron HCL
NATCO files ANDA for Ondansetron
Oct 03, 2005 at 11:31
NATCO files ANDA for Ondansetron,Eyes a pie of US $ 1.3 Billion Global Market
Glenmark receives approval for Ondansetron IR & ODT tablets
Jun 29, 2007 at 13:38
Glenmark receives US FDA approval for Ondansetron IR and Ondansetron ODT tablets
Dr Reddys announces final approval of Ondansetron tablets
Dec 27, 2006 at 13:25
Dr Reddys announces final approval of Ondansetron tablets with 180-days of marketing exclusivity
Dr Reddy's gets USFDA nod for Ondansetron
Dec 28, 2006 at 08:28
Dr Reddy's Laboratories Ltd today got the final approval for Ondansetron Hydrochloride, the generic equivalent of the blockbuster drug `Zofran', from the US Food and Drug Administration (USFDA), as well as a 6-month marketing exclusivity.
Glenmark receives tentative approval to mkt Ondansetron HCL
Sep 19, 2006 at 14:30
Glenmark receives US FDA tentative approval to market generic Ondansetron HCL
NATCO files ANDA for Ondansetron
Oct 03, 2005 at 11:31
NATCO files ANDA for Ondansetron,Eyes a pie of US $ 1.3 Billion Global Market
Photos »
/
Follow moneycontrol.com
Facebook
Twitter
Google Plus
RSS
Wap SMS
SMS
Alert
iPad
iPhone
Blackberry
OVI
Android
Window